Constraint satisfaction separates hard requirements that every candidate must meet from soft objectives to optimize within the feasible set. In drug design, this can prevent strong predicted potency from compensating for a failure to meet a structural requirement. section 13.3.1
Molecular design requirements can include:
- Hard constraints: at most one chiral center, molecular weight of 300–500 Da, or a required scaffold. section 13.3.1
- Soft objectives: maximize predicted potency and minimize lipophilicity while satisfying the hard constraints. section 13.3.1
- SMARTS pattern matching or scaffold-constrained generation can enforce structural constraints; a feasible solution must exist. section 13.3.1


